Impact BioMedical Inc. Faces Financial Struggles Amid Biotech Volatility
Impact BioMedical Inc.’s stock price has plummeted to $0.549, a stark contrast to its 52-week high of $6.17, highlighting the company’s precarious financial standing and the inherent risks in the biotech sector.
2 minutes to read